Pages that link to "Q34005217"
Jump to navigation
Jump to search
The following pages link to Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes (Q34005217):
Displaying 40 items.
- The OmpA family of proteins: roles in bacterial pathogenesis and immunity (Q30155223) (← links)
- Expression library immunization confers partial protection against Chlamydia muridarum genital infection. (Q33269889) (← links)
- Saponin-adjuvanted particulate vaccines for clinical use. (Q33999762) (← links)
- Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4( ) type 2 rather than type 1 immune response that is not protective (Q34119773) (← links)
- Immunity to murine chlamydial genital infection (Q34124225) (← links)
- Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins (Q34491620) (← links)
- Recent advances in mucosal vaccines and adjuvants (Q34786990) (← links)
- Chlamydia trachomatisVaccine Research through the Years (Q35071155) (← links)
- Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms (Q35113092) (← links)
- Contemporary approaches to designing and evaluating vaccines against Chlamydia (Q35193566) (← links)
- Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production (Q35689196) (← links)
- Mucosal immunity: overcoming the barrier for induction of proximal responses. (Q35838661) (← links)
- Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine (Q36028197) (← links)
- ISCOM-based vaccines: the second decade. (Q36062124) (← links)
- Delivery of Chlamydia vaccines (Q36316798) (← links)
- Vaccination against chlamydial infections of man and animals (Q36402064) (← links)
- Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection (Q36685400) (← links)
- A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance (Q36845154) (← links)
- Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. (Q36929225) (← links)
- Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis (Q37419766) (← links)
- ISCOMs and ISCOMATRIX. (Q37486921) (← links)
- Human antibody responses to a Chlamydia-secreted protease factor (Q37623832) (← links)
- Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research (Q37712799) (← links)
- The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge (Q37834854) (← links)
- Update on Chlamydia trachomatis Vaccinology (Q37834874) (← links)
- Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice (Q37845082) (← links)
- In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system (Q37848363) (← links)
- Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1 (Q37851361) (← links)
- Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice (Q37856277) (← links)
- Influence of maternal antibodies on Chlamydophila psittaci-specific immune responses in turkeys elicited by naked DNA. (Q37867413) (← links)
- Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis (Q37869851) (← links)
- Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae (Q37870760) (← links)
- The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis (Q37873968) (← links)
- Human airway epithelial cells present antigen to influenza virus-specific CD8 CTL inefficiently after incubation with viral protein together with ISCOMATRIX. (Q40537339) (← links)
- Vaccines against chlamydial infections--a complex but effective strategy for disease control (Q43418549) (← links)
- Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens. (Q47237292) (← links)
- Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties (Q51930932) (← links)
- Seventy Years of Vaccine Research - Limitations of the Past and Directions for the Future (Q61805093) (← links)
- Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits (Q73816620) (← links)
- Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4 T (Q89850495) (← links)